168 related articles for article (PubMed ID: 7710927)
1. Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype.
Kramer R; Weber TK; Arceci R; Ramchurren N; Kastrinakis WV; Steele G; Summerhayes IC
Br J Cancer; 1995 Apr; 71(4):670-5. PubMed ID: 7710927
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
Wojtowicz K; Januchowski R; Nowicki M; Zabel M
Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Nakazima Y; Akiyama S
Biochim Biophys Acta; 1991 Mar; 1073(2):309-15. PubMed ID: 1672608
[TBL] [Abstract][Full Text] [Related]
4. Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells.
Sereš M; Cholujová D; Bubenčíkova T; Breier A; Sulová Z
Int J Mol Sci; 2011; 12(11):7772-84. PubMed ID: 22174631
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
6. The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation.
Bentley J; Quinn DM; Pitman RS; Warr JR; Kellett GL
Cancer Lett; 1997 May; 115(2):221-7. PubMed ID: 9149128
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of GRP78/BiP in P-Glycoprotein-Positive L1210 Cells is Responsible for Altered Response of Cells to Tunicamycin as a Stressor of the Endoplasmic Reticulum.
Šereš M; Pavlíková L; Boháčová V; Kyca T; Borovská I; Lakatoš B; Breier A; Sulová Z
Cells; 2020 Apr; 9(4):. PubMed ID: 32268491
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines.
Izquierdo MA; Neefjes JJ; Mathari AE; Flens MJ; Scheffer GL; Scheper RJ
Br J Cancer; 1996 Dec; 74(12):1961-7. PubMed ID: 8980397
[TBL] [Abstract][Full Text] [Related]
9. L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins.
Pavlikova L; Seres M; Hano M; Bohacova V; Sevcikova I; Kyca T; Breier A; Sulova Z
Molecules; 2017 Jul; 22(7):. PubMed ID: 28671633
[TBL] [Abstract][Full Text] [Related]
10. Functional modulation of multidrug resistance-related P-glycoprotein by Ca(2+)-calmodulin.
Schlemmer SR; Yang CH; Sirotnak FM
J Biol Chem; 1995 May; 270(19):11040-2. PubMed ID: 7744732
[TBL] [Abstract][Full Text] [Related]
11. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
12. Swelling-activated chloride channels in multidrug-sensitive and -resistant cells.
Ehring GR; Osipchuk YV; Cahalan MD
J Gen Physiol; 1994 Dec; 104(6):1129-61. PubMed ID: 7699367
[TBL] [Abstract][Full Text] [Related]
13. Expression of the MDR1 gene and P-glycoprotein in canine mast cell tumor cell lines.
Nakaichi M; Takeshita Y; Okuda M; Nakamoto Y; Itamoto K; Une S; Sasaki N; Kadosawa T; Takahashi T; Taura Y
J Vet Med Sci; 2007 Feb; 69(2):111-5. PubMed ID: 17339753
[TBL] [Abstract][Full Text] [Related]
14. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells.
Homolya L; Holló M; Müller M; Mechetner EB; Sarkadi B
Br J Cancer; 1996 Apr; 73(7):849-55. PubMed ID: 8611394
[TBL] [Abstract][Full Text] [Related]
15. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
[TBL] [Abstract][Full Text] [Related]
17. The human multidrug resistance P-glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy.
Loo TW; Clarke DM
FASEB J; 1999 Oct; 13(13):1724-32. PubMed ID: 10506575
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C.
Yang JM; Sullivan GF; Hait WN
Biochem Pharmacol; 1997 Jun; 53(11):1597-604. PubMed ID: 9264311
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of CD4. Tunicamycin inhibits surface expression.
König R; Ashwell G; Hanover JA
J Biol Chem; 1988 Jul; 263(19):9502-7. PubMed ID: 3259951
[TBL] [Abstract][Full Text] [Related]
20. The multidrug resistance phenotype confers immunological resistance.
Weisburg JH; Curcio M; Caron PC; Raghu G; Mechetner EB; Roepe PD; Scheinberg DA
J Exp Med; 1996 Jun; 183(6):2699-704. PubMed ID: 8676093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
